戻る Agenda
Session 5: Innovative approaches to integrated evidence
Session Chair(s)
Adrian Cassidy, PHD, MSC
Head Global Evidence Generation
Novartis, Switzerland
Michael Lees, MA
Chief Operating Officer and Head of Market Access Strategy
PHMR Ltd, United Kingdom
Session 5: Innovative Approaches to Integrated Evidence
Speaker(s)
Real world evidence in marketing authorisation applications at EMA
Marcia Rueckbeil
European Medicines Agency, Netherlands
Seconded National Expert (Data Analytics and Methods Task Force)
Integrated Evidence Generation: The Innovation Challenge
Angela Ibald-Mulli, DrPH, MBA, MPH, MS
Bayer Pharmaceuticals, Germany
Integrated Evidence Generation Lead Thrombosis
Accessing Multiple Patient Data Sources to Enhance Generation of Real-World Evidence, Outcome Research and Non-Research Evaluations
Baris Erdogan, PHD
Clinerion Ltd, Switzerland
CEO
Accessing Multiple Patient Data Sources to Enhance Generation of Real-World Evidence, Outcome Research and Non-Research Evaluations
Ian Rentsch, JD
Remember the Girls, Germany
Executive Advisor